CSPC Pharmaceutical Group Limited (HKG:1093)
7.69
-0.08 (-1.03%)
At close: Dec 11, 2025
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 88.83 billion as of December 11, 2025. Its market cap has increased by 47.29% in one year.
Market Cap
88.83B
Enterprise Value
80.53B
Revenue
28.65B
Ranking
n/a
PE Ratio
20.07
Stock Price
7.69
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 88.83B, an increase of 12,663.62%. That is a compound annual growth rate of 17.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 88.83B | 61.02% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | 94.80B | -18.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.07B |
| Hansoh Pharmaceutical Group Company | 254.15B |
| JD Health International | 189.85B |
| Innovent Biologics | 144.64B |
| WuXi Biologics | 138.19B |
| Sino Biopharmaceutical | 121.20B |
| Akeso | 109.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.48B |